Wake up daily to our latest coverage of business done better, directly in your inbox.
Get your weekly dose of analysis on rising corporate activism.
The best of solutions journalism in the sustainability space, published monthly.
Select Newsletter
By signing up you agree to our privacy policy. You can opt out anytime.
The international pharmaceuticals industry’s code of conduct has been expanded. The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) code, which will now govern all interactions that member companies have with healthcare professionals, medical institutions and patient organisations, has bolstered its principles on employee training, bribery, clinical trials disclosure and complaints mechanisms.
TriplePundit has published articles from over 1000 contributors. If you'd like to be a guest author, please get in touch!
